Zyglin-M50 Tablet is a combination medication containing Methylcobalamin 500 mcg and Pregabalin 50 mg, formulated for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair, supporting the maintenance of healthy nerve function and aiding in the treatment of peripheral neuropathies. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, acts by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating symptoms such as neuropathic pain, epilepsy, and generalized anxiety disorder. The synergistic effect of these two agents provides effective relief from nerve pain while promoting nerve healing. Zyglin-M50 is indicated for conditions including diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain syndromes. It is also used adjunctively in the management of partial seizures. The medication should be taken as prescribed by a healthcare professional, with dosage adjustments based on clinical response and tolerability. Common side effects may include dizziness, somnolence, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, and it is contraindicated in individuals with known hypersensitivity to its components. Regular monitoring is recommended during prolonged therapy.